755 results on '"Adkins, Douglas"'
Search Results
302. Evaluation of Mini/Micro-Pumps for Micro-Chem-Lab™
303. American Society for Blood and Marrow Transplantation guidelines for training
304. Miniature mobile robots for plume tracking and source localization research
305. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
306. Granulocyte Transfusions
307. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation
308. Innovations in allogeneic stem-cell transplantation
309. Development of a Latching Valve for Micro-Chem-Lab™
310. Modeling transport in gas chromatography columns for the Micro-ChemLab
311. Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor
312. Development of an Electromagnetically Actuated Mercury Microvalve
313. An Investigation of Corrosion in Liquid-Metal Heat Pipes
314. Development of a Micropump for Microelectronic Cooling
315. Persistent Problems of Neutropenia and Thrombocytopenia with Peripheral Blood Stem Cell Transplantation
316. Antiangiogenic Agents for Nonmalignant Brain Tumors.
317. Tandem Transplants in Solid Tumors: Marrow versus Peripheral Stem Cell Transplant: Peripheral Blood Cells as Now Practiced Are Not the Whole Answer
318. Design, Fabrication and Testing of a 15-kW Gas-Fired Liquid-Metal Evaporator
319. Experiments on bench-scale heat-pipe solar receivers.
320. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.
321. Design Considerations for Heat-Pipe Solar Receivers
322. Miniature mobile robots for plume tracking and source localization research.
323. Analyses of Hydrodynamic Forces on Centrifugal Pump Impellers
324. Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial.
325. Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial.
326. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
327. nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
328. Origins of hydrodynamic forces on centrifugal pump impellers
329. Dynamic host immune response in virus-associated cancers.
330. Granulocyte transfusions and cytomegalovirus infection
331. The Great American Degree Machine
332. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
333. Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
334. Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma.
335. Trials in head and neck oncology: Evolution of perioperative adjuvant therapy.
336. Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.
337. T cell subtype profiling measures exhaustion and predicts anti-PD-1 response.
338. Report on Sandia National Laboratories Micro Chemical Analysis System for Simultaneous Detection of CW Agents at STEL Levels.
339. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
340. Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers.
341. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.
342. Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study.
343. PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.
344. High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
345. Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
346. Metastasis occurring eleven years after diagnosis of human papilloma virus-related oropharyngeal squamous cell carcinoma.
347. Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial.
348. Duration of radiation therapy is associated with worse survival in head and neck cancer.
349. Modular manifold for integrated fluidics and electronics
350. Method to fabricate silicon chromatographic column comprising fluid ports
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.